Phone: 1-617-401-8149
Fax: 1-617-606-5019
Email: message@sydlabs.com
Or leave a message with a formal purchase
order (PO) Or credit card.
| Catalog No. | Product Name | Size | List Price (US$) | Quantity |
|---|
Recombinant Mouse IgG2a isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.
Price/availability/specifications subject to change without notice. Unless otherwise indicated, our catalog and customized products are for research use only and not intended for human or animal diagnostic or therapeutic use.
Phone: 1-617-401-8149
Fax: 1-617-606-5019
Email: message@sydlabs.com
Or leave a message with a formal purchase
order (PO) Or credit card.
The in vivo grade recombinant anti-human HLA-DR Mouse IgG2a Kappa monoclonal antibody was produced in mammalian cells.
Clone: L243.
Isotype: Mouse IgG2a Kappa.
Specificity/Sensitivity: The in vivo grade recombinant mouse monoclonal antibody (clone: L243) specifically binds to human HLA-DR.
Applications: ELISA, flow cytometry, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by the human HLA-DR protein.
Formulation: 0.2 μM filtered solution of 1x PBS.
Purity: >95% by SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU/mg of protein as determined by LAL method.
Shipping: The in vivo grade recombinant anti-human HLA-DR antibodies (clone of L243) are shipped with ice pack. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
12 months from date of receipt, -20 to -70°C as supplied.
1 month from date of receipt, 2 to 8°C as supplied.
Citrullinated Vimentin Presented on MHC-II in Tumor Cells Is a Target for CD4+ T-Cell-Mediated Antitumor Immunity
Brentville, V. A., et al. Cancer Res. 2016 Feb 1;76(3):548-60. doi: 10.1158/0008-5472.CAN-15-1085. PMID: 26719533
To construct the plasmid pVitro 2 Chimeric HLA-DR401, cDNA was generated from mRNA isolated from the splenocytes of transgenic HLA-DR4 mice. ...Following sequence confirmation full-length chimeric α chain comprising murine H2-Ea with the human HLA-DRA α 1 domain was ligated into the FspI/EcoRI mcs2 of the vector pVITRO2-hygro-mcs (Invivogen). ...To generate the IFNγ-inducible plasmid pDCGAS chimeric HLA-DR401, the chimeric α and β chains, were cloned into the pDCOrig vector described elsewhere (24) in replacement of the heavy and light chain. ...The CMV promoter within each cassette was excised and replaced with the IFNγ-inducible promoter driving expression of the HLA-DR401 chains within the pDCOrig vector backbone. ...For MHC blocking studies 20 μg/mL of the HLA-DR (clone L243)-specific antibody was added to Elispot assays.
Tags: anti-human HLA-DR L243; anti-human HLA-DR L243 mAb
The Possible Mechanism of Idiosyncratic Lapatinib-Induced Liver Injury in Patients Carrying Human Leukocyte Antigen-DRB1*07:01
Hirasawa, M., et al. PLoS One. 2015 Jun 22;10(6):e0130928. doi: 10.1371/journal.pone.0130928. PMID: 26098642
Although the expressions of these two alleles are highly correlated, comparisons of HLA-DR and HLA-DQ heterodimer protein pairing suggested the HLA-DRB1*07:01 allele provided the simplest causal association with lapatinib-induced ALT elevation. ...In this study, we evaluated the effect of lapatinib on the binding of the known ligand peptides to HLA-DRB1*07:01 and DRB1*15:01 in vitro. ...Also we performed a series of in silico molecular modeling for HLA-DRB1*07:01 and two other HLA-DRs to further assess the possible role of lapatinib on HLA-peptide binding, which could lead to the mechanism of immune-mediated lapatinib-induced liver injury. ...The finding motivated us to predict the possible interaction mode of lapatinib with HLA-DRs. ...In summary, our in vitro experiments revealed that lapatinib enhances binding of the ligand peptide to HLA-DRB1*07:01 preferentially.
Tags: anti-human HLA-DR L243 antibody in vivo; anti-human HLA-DR L243 antibody in animal model
Preserved dendritic cell HLA-DR expression and reduced regulatory T cell activation in asymptomatic Plasmodium falciparum and P. vivax infection
Kho, S., et al. Infect Immun. 2015 Aug;83(8):3224-32. doi: 10.1128/IAI.00226-15. PMID: 26034211
Peripheral blood total DC were identified by flow cytometry as lineage marker-negative HLA-DR+ cells. ...The activation/maturation of circulating blood DC was examined by measuring the median fluorescence intensity of HLA-DR expression. ...In a limited number of samples, additional staining was possible and HLA-DR expression could be examined on two myeloid DC (mDC) subsets, CD1c+ (blood dendritic cell antigen 1 [BDCA-1] positive) mDC (CD1c+ mDC) and CD141+ (BDCA-3 positive) mDC (CD141+ mDC). ...In both mDC subsets, HLA-DR was preserved during asymptomatic infection, but in 3 adults with uncomplicated malaria, HLA-DR expression appeared reduced. ...Total DC HLA-DR expression was inversely correlated with parasitemia in adults with asymptomatic P. falciparum infection (rs = −0.54, P = 0.02, n = 18) and positively correlated in children with asymptomatic P. vivax infection (rs = 0.80, P = 0.01, n = 9).
Tags: anti-human HLA-DR L243 in cancer research; anti-human HLA-DR L243 antibody in cancer research
Differential incorporation of CD45, CD80 (B7-1), CD86 (B7-2), and major histocompatibility complex class I and II molecules into human immunodeficiency virus type 1 virions and microvesicles: implications for viral pathogenesis and immune regulation
Esser, M. T., et al. J Virol. 2001 Jul;75(13):6173-82. doi: 10.1128/JVI.75.13.6173-6182.2001. PMID: 11390619
The HIV virion envelope is enriched for HLA-DR but not DP or DQ (2, 6, 18, 45), and virion-associated MHC-II can bind and present the superantigen Staphylococcus enterotoxin B to resting T cells, resulting in T-cell activation. ...Immunofluorescent staining of PBMC and MDMs (3 × 105 per condition) was performed at 4°C for 30 min by using isotype immunoglobulin G1 (IgG1) (X40), IgG2a (X39), and V4 (non-gp120-interacting domain on CD4) and HLA-DR (L243) MAbs from Becton Dickinson Immunocytometry Systems (San Jose, Calif.). ...The HLA-DR genotype of the T1, T2, TBLCL-CD4, and H9 cell lines; the phenotype of the virion envelope; and whether the HIV-1NL4-3-AT2 virions triggered cell death are summarized in Table. ...Future studies will determine whether the HLA-DR phenotype of the virus or the responder PBMC affects HIV-1-triggered apoptosis. ...We thank Mike Grimes and Bill Bohn for the production and characterization of sucrose-banded, purified HIV-1NL4-3, Antonio Valentin and Jim Turpin for the generous gifts of selected HIV-1 isolates, and Darlene Marti and Mary Carrington for HLA-DR genotyping of the PBMC donor and cell lines.
Tags: function of anti-human HLA-DR L243 antibody; bioactivity of anti-human HLA-DR L243 mAb
For more references about Anti-Human HLA-DR Monoclonal Antibody please contact our scientific support team with message@sydlabs.com.
Related Recombinant IgG Reference Antibodies:
In vivo grade recombinant mouse IgG2a isotype control antibody
Syd Labs provides the following recombinant MHC/HLA monoclonal antibodies:
In Vivo Grade Recombinant Anti-mouse MHC Class I (H-2) Monoclonal Antibodies (Clone M1/42.3.9.8.HLK)
In Vivo Grade Recombinant Anti-mouse MHC Class I (H-2Db) Monoclonal Antibodies (Clone 28-14-8S)
In Vivo Grade Recombinant Anti-mouse MHC Class I (H-2Kb) Monoclonal Antibodies (Clone Y-3)
In Vivo Grade Recombinant Anti-mouse MHC Class I (H-2Kb) Monoclonal Antibodies (Clone AF6-88.5.3)
In Vivo Grade Recombinant Anti-mouse MHC Class I (H-2Kd, H-2Dd) Monoclonal Antibodies (Clone 34-1-2S)
In Vivo Grade Recombinant Anti-mouse MHC Class I (H-2Kd) Monoclonal Antibodies (Clone SF1-1.1.10)
In Vivo Grade Recombinant Anti-mouse MHC Class I (H-2Kk, H-2Dk) Monoclonal Antibodies (Clone 15-3-1S)
In Vivo Grade Recombinant Anti-mouse MHC Class I (H-2Kk, H-2Dk) Monoclonal Antibodies (Clone 16-1-2N)
In Vivo Grade Recombinant Anti-mouse MHC Class I (H-2Kk) Monoclonal Antibodies (Clone AF3-12.1.3)
In Vivo Grade Recombinant Anti-mouse MHC Class II (I-A) Monoclonal Antibodies (Clone Y-3P)
In Vivo Grade Recombinant Anti-mouse MHC Class II (I-A/I-E) Monoclonal Antibodies (Clone M5/114.15.2)
In Vivo Grade Recombinant Anti-mouse MHC Class II (I-Ak, I-Ar, I-Af, I-As, I-Ag7) Monoclonal Antibodies (Clone 10-3.6.2)
In Vivo Grade Recombinant Anti-mouse MHC Class II (I-Ek/RT1-D) Monoclonal Antibodies (Clone 14-4-4S)
In Vivo Grade Recombinant Anti-mouse MHC Class II (Beta chain) Monoclonal Antibodies (Clone KL277)
In Vivo Grade Recombinant Anti-human HLA-ABC Monoclonal Antibodies (Clone W6/32)
In Vivo Grade Recombinant Anti-human HLA-DR Monoclonal Antibodies (Clone L243)
In Vivo Grade Recombinant Anti-human HLA-DR/DP/DQ Monoclonal Antibodies (Clone F3.3)
In Vivo Grade Recombinant Anti-human HLA Class I Heavy Chain Monoclonal Antibodies (Clone HC10)
In Vivo Grade Recombinant Anti-human HLA class II DR/DQ Monoclonal Antibodies (Clone 9.3F10)
In Vivo Grade Recombinant Anti-human MHC Class II HLA-DP/DQ/DR Monoclonal Antibodies (Clone IVA12)
Recombinant Anti-human HLA-ABC Monoclonal Antibodies (Clone W6/32) for flow cytometry
Recombinant Anti-human HLA-DR Monoclonal Antibodies (Clone L243) for flow cytometry
Recombinant Anti-human HLA-DR/DP/DQ Monoclonal Antibodies (Clone F3.3) for flow cytometry
Recombinant Anti-human HLA Class I Heavy Chain Monoclonal Antibodies (Clone HC10) for flow cytometry
Recombinant Anti-human HLA class II DR/DQ Monoclonal Antibodies (Clone 9.3F10) for flow cytometry
Copyright © 2009-2025 sydlabs.com. All rights reserved.
Use of this website means that you have read, understood, and accepted the Syd Labs Privacy Policy and Terms & Conditions.
Friend Link: Ushelf